Month |
Publication |
Title |
| December |
Business Line |
Focus on basics pays for Orchid Chem |
| October |
The Economic Times |
Orchid posts 115 per cent increase in net profit |
| October |
The Economic Times |
Orchid Chemical Q2 net up two-fold at Rs 63.27 cr |
| September |
The Financial Express |
When social responsibility means more than opening a school ... |
| September |
The Hindu |
Orchid to focus on safety procedures |
| July |
The Economic Times |
Orchid receives FDA approval for antibiotic drug |
| July |
The Economic Times |
Orchid Chemicals Q1 net profit up 250 pc |
| July |
The Economic Times |
Orchid gets USFDA nod for Cefdinir |
| July |
Business Line |
Orchid gets US FDA nod for Cefdinir |
| July |
Business Line |
Orchid Chem launching 3 products in US this year |
| July |
The Hindu |
Orchid to line up new drugs |
| July |
The Hindu |
Orchid Chemicals’ net profit surges |
| June |
The Economic Times |
Orchid gets USFDA nod to launch Terbinafine |
| April |
The Hindu |
Orchid to foray into Canadian generics market |
| February |
Business Line |
Orchid in marketing pact with Actavis |
| February |
Business Line |
Orchid Chem raises $200 m through FCCBs |
| February |
The Economic Times |
Growth zone ahead |
| January |
Business Line |
Orchid Chemicals gearing up for European foray |
| January |
Business Line |
Orchid facility gets UK approval |
| January |
Business Standard |
We will reduce interest costs |
| January |
The Economic Times |
Orchid to acquire European firm |
